Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel
H
H
Department of Internal Medicine III, University of Ulm, Germany.
Allan
N C
NC
Baccarani
M
M
Guilhot
F
F
Hehlmann
R
R
Horowitz
M
M
Kluin-Nelemans
J
J
Schaefer
U
U
Storb
R
R
Thaler
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea